Interleukin 1 beta polymorphism (-511) and risk of stroke due to small vessel disease

Cerebrovascular Diseases

Volumn 20, Issue 5, 2005, Pages 299-303

  Dziedzic, Tomasz ^a   Slowik, Agnieszka ^a   Pera, Joanna ^a   Szczudlik, Andrzej ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Gene polymorphism; Interleukin 1; Small vessel disease stroke

Indexed keywords

INTERLEUKIN 1BETA;

ALLELE; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RESTRICTION MAPPING; RISK FACTOR; STROKE;

AGED; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR CIRCULATION; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTERLEUKIN-1; LOGISTIC MODELS; MALE; MICROCIRCULATION; MIDDLE AGED; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 27644522711     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000087928     Document Type: Article

References (26)

1. Emsley HC, Tyrrell PJ: Inflammation and infection in clinical stroke. J Cereb Blood Flow Metab 2002;22:1399-1419.
2. Rost NS, Wolf PA, Kase CS, Kelly-Hayes M, Silbershatz H, Massaro JM, D'Agostino RB, Franzblau C, Wilson PW: Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: The Framingham study. Stroke 2001;32:2575-2579.
3. Cao JJ, Thach C, Manolio TA, Psaty BM, Kuller LH, Chaves PH, Polak JF, Sutton-Tyrrell K, Herrington DM, Price TR, Cushman M: C-reactive protein, carotid intima-media thickness, and incidence of ischemic stroke in the elderly: The Cardiovascular Health Study. Circulation 2003;108:166-170.
4. Flex A, Gaetani E, Papaleo P, Straface G, Proia AS, Pecorini G, Tondi P, Pola P, Pola R: Proinflammatory genetic profiles in subjects with history of ischemic stroke. Stroke 2004;35:2270-2275.
5. Touzani O, Boutin H, Chuquet J, Rothwell N: Potential mechanisms of interleukin-1 involvement in cerebral ischaemia. J Neuroimmunol 1999;100:203-215.
6. Santtila S, Savinainen K, Hurme M: Presence of the IL-1RA allele 2 (IL1RN*2) is associated with enhanced IL-1beta production in vitro. Scand J Immunol 1998;47:195-198.
7. Nemetz A, Nosti-Escanilla MP, Molnar T, Kope A, Kovacs A, Feher J, Tulassay Z, Nagy F, Garcia-Gonzales MA, Pena AS: IL-1B gene polymorphisms influence the course and severity of inflammatory bowel disease. Immunogenetics 1999;49:527-531.
8. Seripa D, Dobrina A, Margaglione M, Matera MG, Gravina C, Vecile E, Fazio VM: Relevance of interleukin-1 receptor antagonist intron-2 polymorphism in ischemic stroke. Cerebrovasc Dis 2003;15:276-281.
9. Dziedzic T, Slowik A, Pera J, Szczudlik A: Lack of association between interleukin-1 beta polymorphism (-511) and ischaemic stroke. J Neurol Neurosurg Psychiatry 2004;75:170-171.
10. Iacoviello L, Di Castelnuovo A, Gattone M, Pezzini A, Assanelli D, Lorenzet R, Del Zotto E, Colombo M, Napoleone E, Amore C, D'Orazio A, Padovani A, de Gaetano G, Giannuzzi P, Donati MB, IGIGI Investigators: Polymorphisms of the interleukin-1beta gene affect the risk of myocardial infarction and ischemic stroke at young age and the response of mononuclear cells to stimulation in vitro. Arterioscler Thromb Vasc Biol 2005;25:222-227.
11. Jerrard-Dunne P, Cloud G, Hassan A, Markus HS: Evaluating the genetic component of ischemic stroke subtypes: a family history study. Stroke 2003;34:1364-1369.
12. Adams HP, Bendixen BH, Kappelle LJ, and the TOAST Investigators: Classification of subtype of acute ischemic stroke: definitions for use in a multicenter clinical trial. Stroke 1993;24:35-41.
13. Alberti KG, Zimmet PZ: Definition, diagnosis and classification of diabetes mellitus and its complications. 1. Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabetes Med 1998;15:539-553.
14. Kanemoto K, Kawasaki J, Miyamoto T, Obayashi H, Nishimura M: Interleukin (IL)-1β, IL-1α, and IL-1 receptor antagonist gene polymorphism in patients with temporal lobe epilepsy. Ann Neurol 2000;47:571-574.
15. Schulz UG, Rothwell PM: Differences in vascular risk factors between etiological subtypes of ischemic stroke: importance of population-based studies. Stroke 2003;34:2050-2059.
16. von der Thusen JH, Kuiper J, van Berkel TJ, Biessen EA: Interleukins in atherosclerosis: molecular pathways and therapeutic potential. Pharmacol Rev 2003;55:133-166.
17. Joseph L, Fink LM, Hauer-Jensen M: Cytokines in coagulation and thrombosis: a preclinical and clinical review. Blood Coagul Fibrinolysis 2002;13:105-116.
18. Worrall BB, Azhar S, Nyquist PA, Ackerman RH, Hamm TL, DeGraba TJ: Interleukin-1 receptor antagonist gene polymorphisms in carotid atherosclerosis. Stroke 2003; 34: 790-793.
19. Vohnout B, Di Castelnuovo A, Trotta R, D'Orazi A, Panniteri G, Montali A, Donati MB, Arca M, Iacoviello L: Interleukin-1 gene cluster polymorphisms and risk of coronary artery disease. Haematologica 2003;88:54-60.
20. Jerrard-Dunne P, Sitzer M, Risley P, Buehler A, von Kegler S, Markus HS: Inflammatory gene load is associated with enhanced inflammation and early carotid atherosclerosis in smokers. Stroke 2004;35:2438-2443.
21. Bamford J, Sandercock P, Jones L, Warlow C: The natural history of lacunar infarction: the Oxfordshire Community Stroke Project. Stroke 1987;18:545-551.
22. Lammie GA: Pathology of small vessel stroke. Br Med Bull 2000;56:296-306.
23. Castellanos M, Castillo J, Garcia MM, Leira R, Serena J, Chamorro A, Davalos A: Inflammation-mediated damage in progressing lacunar infarctions: a potential therapeutic target. Stroke 2002;33:982-987.
24. Revilla M, Obach V, Cervera A, Davalos A, Castillo J, Chamorro A: A-174G/C polymorphism of the interleukin-6 gene in patients with lacunar infarction. Neurosci Lett 2002;324:29-32.
25. Acalovschi D, Wiest T, Hartmann M, Farahmi M, Mansmann U, Auffarth GU, Grau AJ, Green FR, Grond-Ginsbach C, Schwaninger M: Multiple levels of regulation of the interleukin-6 system in stroke. Stroke 2003;34:1864-1869.
26. Dziedzic T, Gryz EA, Turaj W, Slowik A, Szczudlik A: Serum interleukin-6 soluble receptor in relation to interleukin-6 in stroke patients. J Mol Neurosci 2004;24:293-298.